Search - tctmd.com

Displaying 441 - 460 of 872

Sort: Relevancy | Date

Presentation

Paravalvular Regurgitation after TAVR with the Edwards Sapien Valve in the PARTNER Trial

Presenter: Susheel Kodali

October 08, 2014

News Daily News

More Prosthesis-Patient Mismatch with Surgery vs TAVR, Linked to Worse Outcomes

October 03, 2014

News Industry News

Boston Scientific Enrolls First Patients In U.S. Trial Of The Lotus™ Valve System

September 23, 2014

Presentation TCT 2014

Thoughtful Insights

Presenter: Michael J. Mack

September 17, 2014

Presentation TCT 2014

Thoughtful Insights

Presenter: Philippe Pibarot

September 17, 2014

Presentation TCT 2014

Thoughtful Insights

Presenter: James B. Hermiller Jr

September 17, 2014

Presentation TCT 2014

Case Presentation

Presenter: Tamim Nazif

September 17, 2014

Presentation TCT 2014

TCT 699: The Effect of Tricuspid Regurgitation and Right Ventricular Dysfunction on Mortality in High-Risk Patients Undergoing Transcatheter Aortic Valve Replacement: An Analysis of the PARTNER II Inoperable Cohort

Presenter: James B. Hermiller Jr, Susheel Kodali, Augusto D. Pichard, Alan Zajarias

September 16, 2014

Presentation TCT 2014

Case Presentation

Presenter: Tamim Nazif

September 16, 2014

Presentation TCT 2014

TAVR Controversies: Strokes and Paravalvular Regurgitation Will New TAVR Systems or Accessory Devices Make a Difference?

Presenter: Matthew G. Hillebrenner, Michael J. Mack, Daniel I. Simon, Samir R. Kapadia

September 16, 2014

Presentation TCT 2014

Case Presentation

Presenter: Hemal Gada

September 16, 2014

Presentation TCT 2014

Case Presentation

Presenter: Philip Green

September 16, 2014

Presentation TCT 2014

Case Presentation

Presenter: Isaac George

September 16, 2014

Presentation TCT 2014

CON Problematic and Challenged

Presenter: Steven F. Bolling

September 16, 2014

Presentation TCT 2014

PRO Continued Optimism

Presenter: Francesco Maisano

September 16, 2014

Presentation TCT 2014

Transcatheter Edge-to-edge Repair for Functional Mitral Regurgitation: Real-World Clinical Outcomes

Presenter: Xavier Mill?n

September 16, 2014

Presentation TCT 2014

Clinical Impact and Evolution Of Mitral Regurgitation Following Transcatheter Aortic Valve Replacement: A Meta-Analysis

Presenter: Luis Nombela-Franco

September 16, 2014

Presentation TCT 2014

Trancatheter Aortic Valve Implantation in Patients with Pure Severe Native Aortic Regurgitation: Results after 3 Year of Follow-Up

Presenter: Marco Luciano Rossi

September 16, 2014

Presentation TCT 2014

Outcomes Following Percutaneous Reduction of Significant Mitral Regurgitation in EVEREST II High Risk Patients Who Were Symptomatic Despite Cardiac Resynchronization Therapy

Presenter: Saibal Kar

September 16, 2014

Presentation TCT 2014

Characterization of the Impact of Transcatheter Aortic Valve Implantation on Mitral Regurgitation Regression in High Risk Patients With Aortic Stenosis

Presenter: Ran Kornowski

September 16, 2014

Advertisement

Paravalvular Regurgitation after TAVR with the Edwards Sapien Valve in the PARTNER Trial

More Prosthesis-Patient Mismatch with Surgery vs TAVR, Linked to Worse Outcomes

Boston Scientific Enrolls First Patients In U.S. Trial Of The Lotus™ Valve System

Thoughtful Insights

Thoughtful Insights

Thoughtful Insights

Case Presentation

TCT 699: The Effect of Tricuspid Regurgitation and Right Ventricular Dysfunction on Mortality in High-Risk Patients Undergoing Transcatheter Aortic Valve Replacement: An Analysis of the PARTNER II Inoperable Cohort

Case Presentation

TAVR Controversies: Strokes and Paravalvular Regurgitation Will New TAVR Systems or Accessory Devices Make a Difference?

Case Presentation

Case Presentation

Case Presentation

CON Problematic and Challenged

PRO Continued Optimism

Transcatheter Edge-to-edge Repair for Functional Mitral Regurgitation: Real-World Clinical Outcomes

Clinical Impact and Evolution Of Mitral Regurgitation Following Transcatheter Aortic Valve Replacement: A Meta-Analysis

Trancatheter Aortic Valve Implantation in Patients with Pure Severe Native Aortic Regurgitation: Results after 3 Year of Follow-Up

Outcomes Following Percutaneous Reduction of Significant Mitral Regurgitation in EVEREST II High Risk Patients Who Were Symptomatic Despite Cardiac Resynchronization Therapy

Characterization of the Impact of Transcatheter Aortic Valve Implantation on Mitral Regurgitation Regression in High Risk Patients With Aortic Stenosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content